PANGENOTYPIC HCV REGIMENS: ALL FOR ONE AND ONE FOR ALL It’s no secret the...
Read More
This edition contains the following: TLI Welcomes Dr. Fabian Rodas Opening of Texas Liver Tumor...
Transient Elastography (FibroScan) Non-Invasive Liver Fibrosis Assessment Accurately staging liver disease is important in...
Liver disease is serious and can go undetected for years. That is why the...
Study findings shed light on effective new HCV therapy that will treat patients who...
This edition contains the following: Dr. Naim Alkhouri, Joins Texas Liver Institute and UT Health...
SAN ANTONIO, /PRNewswire/ — The Texas Liver Institute announced that Dr. Naim Alkhouri has joined...